Results 11 to 20 of about 86,839 (276)

The Multifaceted Immunology of Cytokine Storm Syndrome. [PDF]

open access: yesJ Immunol, 2023
Abstract Cytokine storm syndromes (CSSs) are potentially fatal hyperinflammatory states that share the underpinnings of persistent immune cell activation and uninhibited cytokine production. CSSs can be genetically determined by inborn errors of immunity (i.e., familial hemophagocytic lymphohistiocytosis) or develop as a complication of ...
Lee PY, Cron RQ.
europepmc   +3 more sources

Cytokine storm syndrome in severe COVID-19. [PDF]

open access: yesAutoimmun Rev, 2020
Ruscitti P   +3 more
europepmc   +5 more sources

Acute respiratory distress syndrome caused by carbon monoxide poisoning and inhalation injury recovered after extracorporeal membrane oxygenation along with direct hemoperfusion with polymyxin B-immobilized fiber column: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Inhalation injury from smoke or chemical products and carbon monoxide poisoning are major causes of death in burn patients from fire accidents.
Ji Hoon Jang   +9 more
doaj   +1 more source

Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity [PDF]

open access: yes, 2020
On 7 January 2020, researchers isolated and sequenced in China from patients with severe pneumonitis a novel coronavirus, then called SARS-CoV-2, which rapidly spread worldwide, becoming a global health emergency.
Diamanti, A. P.   +4 more
core   +2 more sources

Serum Cytokine Profiling Differentiates Underlying Diseases in Cytokine Storm Syndrome. [PDF]

open access: yesArthritis Rheumatol
Objective Cytokine storm syndrome (CSS), commonly associated with hemophagocytic lymphohistiocytosis (HLH), is a fatal hyperinflammatory syndrome. Differentiating the underlying diseases responsible for CSS is essential for timely therapeutic decisions.
Kaneko S   +42 more
europepmc   +3 more sources

IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6

open access: yesНаучно-практическая ревматология, 2020
The Coronavirus Disease 2019 (COVID-19) pandemic has drawn closer attention than ever before to the problems of the immunopathology of human diseases, many of which have been reflected when studying immune-mediated inflammatory rheumatic diseases (IIRDs).
E. L. Nasonov
doaj   +1 more source

Continuous IV infusion of anakinra

open access: yesFrontiers in Pharmacology, 2023
Objective: A review of the use of continuous IV infusion of anakinra; a description of the protocol for continuous IV infusion of anakinra in the treatment of cytokine storm developed over the past 4 years at a tertiary level academic medical center in ...
Brittney N. Saunders   +3 more
doaj   +1 more source

Cytokines and microRNAs in SARS-CoV-2: What do we know?

open access: yesMolecular Therapy: Nucleic Acids, 2022
The coronavirus disease 2019 (COVID-19) pandemic constitutes a global health emergency. Currently, there are no completely effective therapeutic medications for the management of this outbreak.
Fahimeh Zamani Rarani   +5 more
doaj   +1 more source

Repurposing Interleukin-6 Inhibitors to Combat COVID-19. [PDF]

open access: yes, 2020
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a pandemic with major implications across the world. One of the most frequent causes of death from SARS-CoV-2 is fatal pneumonia from coronavirus disease 2019 (COVID-19), which is associated
Kato, Shumei, Kurzrock, Razelle
core   +1 more source

Home - About - Disclaimer - Privacy